Dermatan sulphate sodium
Dermatan sulphate sodium, a glycosaminoglycan and thrombin inactivator, exhibits antithrombotic activity by selectively catalyzing the inactivation of thrombin via heparin cofactor II, without interaction with antithrombin III. This compound is noted for its high bioavailability and ability to reduce Bleomycin-induced pulmonary fibrosis damage .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
54328-33-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1198820-01 0.02 mg (E-Coli)
Recombinant Leuconostoc citreum 3-dehydroquinate synthase (aroB)
Ask
View Details 
MBS1198820-02 0.02 mg (Yeast)
Recombinant Leuconostoc citreum 3-dehydroquinate synthase (aroB)
Ask
View Details MBS1198820-03 0.1 mg (E-Coli)
Recombinant Leuconostoc citreum 3-dehydroquinate synthase (aroB)
Ask
View Details MBS1198820-04 0.1 mg (Yeast)
Recombinant Leuconostoc citreum 3-dehydroquinate synthase (aroB)
Ask
View Details MBS1198820-05 0.02 mg (Baculovirus)
Recombinant Leuconostoc citreum 3-dehydroquinate synthase (aroB)
Ask
View Details 
MBS1198820-06 0.02 mg (Mammalian-Cell)
Recombinant Leuconostoc citreum 3-dehydroquinate synthase (aroB)
Ask
View Details